BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25265912)

  • 1. The development of immunoconjugates for targeted cancer therapy.
    Smaglo BG; Aldeghaither D; Weiner LM
    Nat Rev Clin Oncol; 2014 Nov; 11(11):637-48. PubMed ID: 25265912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted drug delivery using immunoconjugates: principles and applications.
    Pasquetto MV; Vecchia L; Covini D; Digilio R; Scotti C
    J Immunother; 2011; 34(9):611-28. PubMed ID: 21989410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arming antibodies: prospects and challenges for immunoconjugates.
    Wu AM; Senter PD
    Nat Biotechnol; 2005 Sep; 23(9):1137-46. PubMed ID: 16151407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD30-targeting immunoconjugates and bystander effects.
    Masuda S; Miyagawa S; Sougawa N; Sawa Y
    Nat Rev Clin Oncol; 2015 Apr; 12(4):. PubMed ID: 25734636
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted therapy of cancer: new prospects for antibodies and immunoconjugates.
    Sharkey RM; Goldenberg DM
    CA Cancer J Clin; 2006; 56(4):226-43. PubMed ID: 16870998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant antibodies: from the laboratory to the clinic.
    Albrecht H; DeNardo SJ
    Cancer Biother Radiopharm; 2006 Aug; 21(4):285-304. PubMed ID: 16999595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology insight: cytotoxic drug immunoconjugates for cancer therapy.
    Ricart AD; Tolcher AW
    Nat Clin Pract Oncol; 2007 Apr; 4(4):245-55. PubMed ID: 17392715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.
    Brumlik MJ; Daniel BJ; Waehler R; Curiel DT; Giles FJ; Curiel TJ
    Expert Opin Drug Deliv; 2008 Jan; 5(1):87-103. PubMed ID: 18095930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-drug conjugates: an emerging modality for the treatment of cancer.
    Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O
    Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting report on the Ninth Conference on Cancer Therapy with Antibodies and Immunoconjugates.
    Sharkey RM; Sausville EA; Goldenberg DM
    Cancer Res; 2003 Nov; 63(22):8069-71. PubMed ID: 14633741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in cancer-targeted antibody-drug conjugates.
    Bidard FC; Trédan O
    Target Oncol; 2014 Mar; 9(1):1-8. PubMed ID: 24221961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abstracts from the Eleventh Conference on Cancer Therapy with Antibodies and Immunoconjugates. October 12-14, 2006. Parsippany, New Jersey, USA.
    Cancer Biother Radiopharm; 2006 Aug; 21(4):382-405. PubMed ID: 16999603
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody drug conjugates: Progress, pitfalls, and promises.
    Mukherjee A; Waters AK; Babic I; Nurmemmedov E; Glassy MC; Kesari S; Yenugonda VM
    Hum Antibodies; 2019; 27(1):53-62. PubMed ID: 30223393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bispecific antibodies and ADCs: Once and future kings?
    Reichert JM
    MAbs; 2011; 3(4):329-30. PubMed ID: 21654205
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted Therapy With Immunoconjugates for Multiple Myeloma.
    Bruins WSC; Zweegman S; Mutis T; van de Donk NWCJ
    Front Immunol; 2020; 11():1155. PubMed ID: 32636838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the treatment of hematologic malignancies using immunoconjugates.
    Palanca-Wessels MC; Press OW
    Blood; 2014 Apr; 123(15):2293-301. PubMed ID: 24578502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody delivery of drugs and radionuclides: factors influencing clinical pharmacology.
    Prabhu S; Boswell CA; Leipold D; Khawli LA; Li D; Lu D; Theil FP; Joshi A; Lum BL
    Ther Deliv; 2011 Jun; 2(6):769-91. PubMed ID: 22822508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Advances in Oncology.
    Liu J; Pandya P; Afshar S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-cytokine fusion proteins.
    Kontermann RE
    Arch Biochem Biophys; 2012 Oct; 526(2):194-205. PubMed ID: 22445675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-targeted chemotherapy with immunoconjugates of calicheamicin.
    Damle NK
    Expert Opin Biol Ther; 2004 Sep; 4(9):1445-52. PubMed ID: 15335312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.